DEXRAZOXANE
- Product NDC
- 55150-434
- 11-digit product format
- 551500434
- Labeler code
- 55150
- Product ID
- 55150-434_cb72203a-0b09-42d5-bf51-7f479feb3adb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DEXRAZOXANE
- Dosage form
- KIT
- Labeler
- AuroMedics Pharma LLC
- Application
- ANDA200752
- Marketing category
- ANDA
- Marketing start
- 2016-05-12
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200752-001 | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 |
| A200752-002 | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A200752-001 | AP |
| A200752-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-10-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2011-10-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A200752-001 | DEXRAZOXANE HYDROCHLORIDE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A200752-002 | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2011-10-19 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A200752-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200752-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200752-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200752-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200752-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200752-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200752-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200752-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200752-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200752-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200752-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200752-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200752-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200752-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200752-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200752-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200752-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200752-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200752-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200752-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200752-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200752-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200752-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200752-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200752-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200752-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200752-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A200752-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200752-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200752-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200752-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200752-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200752-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200752-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200752-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200752-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A200752-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200752-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A200752-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A200752-002 | AP | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DEXRAZOXANE
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1736585 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| cb72203a-0b09-42d5-bf51-7f479feb3adb | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 29e688b2-4dc9-4153-a703-360ac9c231b8 | Product name | 2 | 20260112 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 0acaa005-650f-0752-3fb2-220e08af175e | Product name | 2 | 20190219 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55150-434-01 | DEXRAZOXANE | 01 in 1 PACKAGE | KIT | 01 | 3 | |
| 55150-434-02 | DEXRAZOXANE | 01 in 1 PACKAGE | KIT | 01 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55150-434-01 | EA - Each | 55150-434 | 5601c4a5-e113-494f-b8a6-e384abc5a270 | 1 | 2022-11-07 |
| 55150-434-02 | EA - Each | 55150-434 | 35d4a90d-d61a-49e9-ac4a-a7043caf2850 | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55150-434 | DEXRAZOXANE KIT [EUGIA US LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241109_be9ac1e9-21a9-439a-9029-9f03513220ea.zip |
| 55150-434 | DEXRAZOXANE KIT [AUROMEDICS PHARMA LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220721_cb72203a-0b09-42d5-bf51-7f479feb3adb.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXRAZOXANE | DEXRAZOXANE | Eugia US LLC | be9ac1e9-21a9-439a-9029-9f03513220ea | 2024-11-02 | Warnings, Adverse reactions | 200752 ANDA200752 55150-434 |
| DEXRAZOXANE | DEXRAZOXANE | AuroMedics Pharma LLC | cb72203a-0b09-42d5-bf51-7f479feb3adb | 2022-07-19 | Warnings, Adverse reactions | 200752 ANDA200752 55150-434 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1736585 | dexrazoxane 250 MG Injection | PSN | be9ac1e9-21a9-439a-9029-9f03513220ea | 3 |
| 1736590 | dexrazoxane 500 MG Injection | PSN | be9ac1e9-21a9-439a-9029-9f03513220ea | 3 |
| 1736585 | dexrazoxane 250 MG Injection | SCD | be9ac1e9-21a9-439a-9029-9f03513220ea | 3 |
| 1736590 | dexrazoxane 500 MG Injection | SCD | be9ac1e9-21a9-439a-9029-9f03513220ea | 3 |
| 1736590 | dexrazoxane (as dexrazoxane HCl) 500 MG Injection | SY | be9ac1e9-21a9-439a-9029-9f03513220ea | 3 |
| 1736585 | dexrazoxane 250 MG Injection | PSN | cb72203a-0b09-42d5-bf51-7f479feb3adb | 1 |
| 1736585 | dexrazoxane 250 MG Injection | SCD | cb72203a-0b09-42d5-bf51-7f479feb3adb | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55150-434-01 | 55150043401 | 1 KIT in 1 PACKAGE (55150-434-01) * 25 mL in 1 VIAL, SINGLE-DOSE (55150-432-01) * 25 mL in 1 VIAL (55150-433-01) | 1 kit | 2016-05-12 | 0000-00-00 | No | No | Current |
| 55150-434-02 | 55150043402 | 1 KIT in 1 PACKAGE (55150-434-02) * 25 mL in 1 VIAL, SINGLE-DOSE (55150-432-02) * 25 mL in 1 VIAL (55150-433-02) | 1 kit | 2016-05-12 | 0000-00-00 | No | No | Current |